FDA Inspection 1216544 — Indrayani Hospital and Cancer Institute
The FDA completed an inspection of Indrayani Hospital and Cancer Institute on August 11, 2023 in Alandi Devachi. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Alandi Devachi (India)
Additional Details
Clinical BA/BE